Table_1_Biologics for psoriasis patients under 18 years of age: Real-world evidence from the Chinese psoriasis real world evidence research group.pdf

BackgroundTreatment for pediatric psoriasis is challenging because of the lack of real-world evidence, especially for biological therapies.ObjectivesThis study evaluated the efficacy and safety of biologics in children with psoriasis based on real-world evidence.MethodsPediatric psoriasis patients aged

儿童银屑病背景治疗面临挑战，主要由于缺乏真实世界证据，尤其是在生物治疗方面。研究目标：本研究旨在基于真实世界证据评估生物制剂在儿童银屑病患者中的疗效与安全性。研究方法：纳入了特定年龄段的儿童银屑病患者群体。